Harnessing Alternative Resources to Aid Kenyans With Acute Illness (HARAKA-2)
12. april 2020 oppdatert av: Dr. Wangari Waweru-Siika, Aga Khan University
Impact of Nurse-Led Focused Cardiac Ultrasound Versus Usual Care on Time to Diagnosis in Adults With Cardiorespiratory Failure: A Two-Cluster Stepped Wedge Clinical Feasibility Trial
Kenya does not have enough experts to perform heart scans in patients who are very sick and in need of urgent intervention.
The purpose of this research is to find out whether training Kenyan nurses to perform basic heart scans would shorten the time it takes to know whether the heart and lungs are working normally in very sick patients, to guide treatment.
Patients will be placed into one of two groups: One group will have a quick scan of the heart and lungs carried out by trained nurses to see how well these organs are working, in addition to receiving the normal care offered at the hospital.
The other group will receive the normal care offered in the hospital only and will not have a scan performed by these nurses.
The time it takes to make a diagnosis between the two groups will then be compared.
Should the group that has heart scans by nurses be found to spend less time waiting for a diagnosis to be made, more nurses in Kenya will be trained to provide this service, to minimise delays in our emergency departments.
Studieoversikt
Status
Ukjent
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Echocardiography is a useful, non-invasive diagnostic tool in time-critical emergencies.
A national shortage of cardiologists and of doctors in Kenya however further compounds the problem of insufficient staff for emergency care and of any capacity building efforts.
To achieve the goals of Sustainable Development Goal Number 3 (SDG-3) and realise the government's vision of universal healthcare for all, alternatives to the human resource challenge are key.
Modifying the Scope of Practice of Kenyan nurses is one possible solution.
Task-shifting traditionally cardiologist roles such as focused cardiac ultrasound (FoCUS) could shorten the time it takes to make a diagnosis in patients with cardiorespiratory failure of likely cardiac origin, making prolonged turnaround times in our public facilities a thing of the past.
Our overarching aim is to harness the power of nurses doing FoCUS.
The central hypothesis of this work is that in patients with cardiorespiratory failure, a nurse-led FoCUS-guided service would shorten time to diagnosis, supporting interventions and improving outcomes among the critically ill.
Insight into potential barriers and enablers for the implementation of a nurse-performed FoCUS service in Kenya is crucial for the success of such a service redesign.
Studietype
Intervensjonell
Registrering (Forventet)
732
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
Any one of:
- Systolic blood pressure <90 millimetres of mercury (mmHg)
- Mean arterial pressure (MAP)<65 millimetres of mercury (mmHg)
- Shock index >1 (heart rate/systolic blood pressure)
- Respiratory rate > 30 breaths/minute
- Oxygen saturations <94%
- Arterial oxygen partial pressure (paO2) <60 millimetres of mercury (mmHg)
- Arterial carbon dioxide partial pressure (paCO2) >50 millimetres of mercury(mmHg)
Exclusion Criteria:
- Trauma
- Pregnancy
- Patients requiring immediate life-saving interventions eg cardiopulmonary resuscitation (CPR) or defibrillation
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Diagnostisk
- Tildeling: Ikke-randomisert
- Intervensjonsmodell: Sekvensiell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: Usual care
The control arm will consist of usual care ie a combination of physical examination, lab tests and imaging.
The need for a formal echocardiographic evaluation by a cardiologist or cardiac sonographer in patients assigned to the control arm will be at the discretion of the clinical teams, as is usual care at the Kenyatta National Hospital (KNH) and Aga Khan University Hospital Nairobi (AKUHN).
A diagnosis will be selected based on the same pre-defined checklist and the time the diagnosis is made recorded.
|
The control arm will consist of usual care ie a combination of physical examination, lab tests and imaging.
The need for a formal echocardiographic evaluation by a cardiologist or cardiac sonographer in patients assigned to the control arm will be at the discretion of the clinical teams, as is usual care at KNH and AKUHN
|
|
Eksperimentell: Nurse-performed focused cardiac ultrasound (FoCUS)
The experimental arm will consist of nurse-performed FoCUS for patients with cardiorespiratory failure.
A FoCUS-trained nurse will perform a FoCUS examination within 30 minutes of triage by the triage clinician.
The Philips Lumify® handheld ultrasound device (HUD) with a phased array probe will be used and studies limited to a maximum of 10 minutes each.
A presumptive diagnosis will then be selected by the nurse from a FoCUS checklist based on pre-defined thresholds for each FoCUS target condition and the time the diagnosis is made recorded.
Additional imaging and lab tests may be requested at the discretion of the clinical team but the FoCUS nurses will be blinded to the results of these.
|
A FoCUS-trained nurse will perform a FoCUS examination within 30 minutes of triage by the triage clinician.
The Philips Lumify® handheld ultrasound device (HUD) with a phased array probe will be used and studies limited to a maximum of 10 minutes each.
A presumptive diagnosis will then be selected by the nurse from a FoCUS checklist based on pre-defined thresholds for each FoCUS target condition and the time the diagnosis is made recorded.
Additional imaging and lab tests may be requested at the discretion of the clinical team but the FoCUS nurses will be blinded to the results of these.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Time to diagnosis
Tidsramme: 24 hours
|
Difference in median time to diagnosis between nurse-performed FoCUS and usual care.
|
24 hours
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of patients with cardiorespiratory failure who have a FoCUS exam performed in A&E
Tidsramme: 10 months
|
Number of patients with cardiorespiratory failure who have a FoCUS
|
10 months
|
|
Proportion of patients with cardiorespiratory failure who have a FoCUS exam performed in A&E
Tidsramme: 10 months
|
Proportion of patients with cardiorespiratory failure who have a FoCUS
|
10 months
|
|
Diagnostic accuracy of nurse-performed FoCUS
Tidsramme: 10 months
|
Sensitivity and specificity of novice FoCUS compared to a reference standard (cardiologist opinion)
|
10 months
|
|
Number of FoCUS protocol components suitable for inclusion in a local FoCUS curriculum
Tidsramme: 10 months
|
Number of FoCUS protocol components suitable for inclusion in a local FoCUS curriculum
|
10 months
|
|
Proportion of novice scanners able to access remote supervision for FoCUS practice.
Tidsramme: 10 months
|
Proportion of novice scanners able to access remote supervision for FoCUS practice.
|
10 months
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Etterforskere
- Hovedetterforsker: Wangari Waweru-Siika, FRCA, Aga Khan University, Nairobi
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Forventet)
1. juni 2020
Primær fullføring (Forventet)
30. april 2021
Studiet fullført (Forventet)
30. april 2021
Datoer for studieregistrering
Først innsendt
7. april 2020
Først innsendt som oppfylte QC-kriteriene
12. april 2020
Først lagt ut (Faktiske)
14. april 2020
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
14. april 2020
Siste oppdatering sendt inn som oppfylte QC-kriteriene
12. april 2020
Sist bekreftet
1. april 2020
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- 31-20
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
JA
IPD-planbeskrivelse
Available on request
IPD-delingstidsramme
6 months after publication
Tilgangskriterier for IPD-deling
Available on request
IPD-deling Støtteinformasjonstype
- STUDY_PROTOCOL
- SEVJE
- ICF
- ANALYTIC_CODE
- CSR
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .